Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bruce Spinowitz, Roberto Pecoits-Filho, Wolfgang C. Winkelmayer, Pablo E. Pergola, Samuel Rochette, Philippe Thompson-Leduc, Patrick Lefebvre, Gigi Shafai, Ana Bozas, Myrlene Sanon & Holly B. Krasa. (2019) Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. Journal of Medical Economics 22:6, pages 593-604.
Read now
Read now
LeeAnn Braun, Vipan Sood, Susan Hogue, Bonnie Lieberman & Catherine Copley-Merriman. (2012) High burden and unmet patient needs in chronic kidney disease. International Journal of Nephrology and Renovascular Disease 5, pages 151-163.
Read now
Read now
Articles from other publishers (26)
Jianzhen Zhang, Vishal Diwan, Zaimin Wang, Helen G. Healy, Sree Krishna Venuthurupalli, Rajitha Abeysekera & Wendy E. Hoy. (2023) The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study. International Journal of Nephrology 2023, pages 1-11.
Crossref
Crossref
Lois Lamerato, Glen James, Heleen van Haalen, Katarina Hedman, James A. Sloand, Amy Tang, Eric T. Wittbrodt & Jerry Yee. (2022) Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study. BMC Nephrology 23:1.
Crossref
Crossref
Wushan Pan, Yong Han, Haofei Hu & Yongcheng He. (2022) Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients. BMC Nephrology 23:1.
Crossref
Crossref
Jiang Liu, Muhammad Chaudhry, Fang Bai, Justin Chuang, Hibba Chaudhry, Ala-Eddin Yassin Al-Astal, Ying Nie, Vincent Sollars, Komal Sodhi, Paul Seligman & Joseph I. Shapiro. (2022) Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57BL/6 mice. American Journal of Physiology-Renal Physiology 322:6, pages F655-F666.
Crossref
Crossref
Eric T Wittbrodt, Glen James, Supriya Kumar, Heleen van Haalen, Hungta Chen, James A Sloand & Kamyar Kalantar-Zadeh. (2022) Contemporary outcomes of anemia in US patients with chronic kidney disease. Clinical Kidney Journal 15:2, pages 244-252.
Crossref
Crossref
Jennifer E. Flythe, Niklas Karlsson, Anna Sundgren, Paul Cordero, Amanda Grandinetti, Henry Cremisi & Anna Rydén. (2021) Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrology 22:1.
Crossref
Crossref
Ningyuan Wang, Jiao Pei, Hui Fan, Yaseen Ali, Anna Prushinskaya, Jian Zhao & Xingyu Zhang. (2021) Emergency department use by patients with end-stage renal disease in the United States. BMC Emergency Medicine 21:1.
Crossref
Crossref
Masaomi Nangaku, Kazuoki Kondo, Souichirou Takabe, Kiichiro Ueta, Genki Kaneko, Makiko Otsuka, Yutaka Kawaguchi & Yasuhiro Komatsu. (2020) Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan. Therapeutic Apheresis and Dialysis 25:5, pages 642-653.
Crossref
Crossref
Min Fei, Xiang-Qiong Wen, Zhao-Lan Yu, Ting Kang, Wei-Hua Wu & San-Tao Ou. (2021) Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature. World Journal of Clinical Cases 9:15, pages 3680-3688.
Crossref
Crossref
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Ryosuke Koretomo, Kazuo Maeda, Yuya Miyazawa & Hideki Hirakata. (2021) A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study. Kidney Diseases 7:6, pages 494-502.
Crossref
Crossref
Heleen van Haalen, James Sloand, Rebecca Moon, Eirini Palaka, Gary Milligan, Alaster Allum & James Jackson. (2020) Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: Cross sectional analysis of real-world data. Kidney Research and Clinical Practice 39:3, pages 318-333.
Crossref
Crossref
Abduzhappar Gaipov, Alpamys Issanov, Zhanar Mursalova, Nazia Tulegenova, Zoya Kakim, Mukhit Baizakov, Saltanat Tuganbekova & Mohamad Aljofan. (2020) Dose equivalency and efficacy of biosimilar erythropoietin stimulating agents: Data from real clinical practice. Pharmacology Research & Perspectives 8:3.
Crossref
Crossref
Silvia Lentini, Andreas Kaiser, Stefanie Kapsa, Kumi Matsuno & Dorina van der Mey. (2020) Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF–PH inhibitor for the treatment of renal anaemia. European Journal of Clinical Pharmacology 76:2, pages 185-197.
Crossref
Crossref
Pablo E. Pergola, Roberto Pecoits-Filho, Wolfgang C. Winkelmayer, Bruce Spinowitz, Samuel Rochette, Philippe Thompson-Leduc, Patrick Lefebvre, Gigi Shafai, Ana Bozas, Myrlene Sanon & Holly B. Krasa. (2019) Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. PharmacoEconomics - Open 3:4, pages 463-478.
Crossref
Crossref
Geoffrey A Block, Pablo E Pergola, Steven Fishbane, Julian G Martins, Robin D LeWinter, Katrin Uhlig, John F Neylan & Glenn M Chertow. (2019) Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. Nephrology Dialysis Transplantation 34:7, pages 1115-1124.
Crossref
Crossref
Rosi Bissinger, Abdulla Al Mamun Bhuyan, Syed M. Qadri & Florian Lang. (2018) Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. The FEBS Journal 286:5, pages 826-854.
Crossref
Crossref
Tadao Akizawa, Hiroyuki Okumura, Ana Filipa Alexandre, Ayako Fukushima, Grace Kiyabu & Julie Dorey. (2018) Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review. Therapeutic Apheresis and Dialysis 22:5, pages 444-456.
Crossref
Crossref
Luiz H. ArantesJr.Jr., Jeffrey Crawford, Pere Gascon, Mark Latymer, Vincent Launay-Vacher, Catherine Rolland, Florian Scotte & Jay Wish. (2018) A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia. Critical Reviews in Oncology/Hematology 129, pages 79-90.
Crossref
Crossref
Jun Jiang, Lei Lan, Xiaowan Zhou, Li Peng & Wei Ren. (2018) The relationship between haemoglobin level and type 1 diabetic nephropathy in Han patients in Anhui, China. Internal Medicine Journal 48:7, pages 830-835.
Crossref
Crossref
David Goldsmith, Frank Dellanna, Martin Schiestl, Andriy Krendyukov & Christian Combe. (2018) Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?. Clinical Drug Investigation 38:6, pages 481-490.
Crossref
Crossref
Hyoungnae Kim, Hae-Ryong Yun, Seohyun Park, Jong Hyun Jhee, Jung Tak Park, Tae-Hyun Yoo, Kyu-Beck Lee, Yeong-Hoon Kim, Su-Ah Sung, Joongyub Lee, Shin-Wook Kang, Kyu Hun Choi, Curie Ahn & Seung Hyeok Han. (2018) High serum adiponectin is associated with anemia development in chronic kidney disease: The results from the KNOW-CKD study. Cytokine 103, pages 1-9.
Crossref
Crossref
Sang-Ryol Ryu, Sue K. Park, Ji Yong Jung, Yeong Hoon Kim, Yun Kyu Oh, Tae Hyun Yoo & Suah Sung. (2017) The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). Journal of Korean Medical Science 32:2, pages 249.
Crossref
Crossref
Ya Li, Hao Shi, Wei-Ming Wang, Ai Peng, Geng-Ru Jiang, Jin-Yuan Zhang, Zhao-Hui Ni, Li-Qun He, Jian-Ying Niu, Nian-Song Wang, Chang-Lin Mei, Xu-Dong Xu, Zhi-Yong Guo, Wei-Jie Yuan, Hai-Dong Yan, Yue-Yi Deng, Chen Yu, Jun Cen, Yun Zhang & Nan Chen. (2016) Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease. Medicine 95:24, pages e3872.
Crossref
Crossref
Simon D. S. Fraser, Paul J. Roderick, Carl R. May, Natasha McIntyre, Christopher McIntyre, Richard J. Fluck, Adam Shardlow & Maarten W. Taal. (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrology 16:1.
Crossref
Crossref
Melissa E. Stauffer & Tao Fan. (2014) Prevalence of Anemia in Chronic Kidney Disease in the United States. PLoS ONE 9:1, pages e84943.
Crossref
Crossref
Javier Soto ÁlvarezJavier Soto Álvarez. 2012. Evaluación económica de medicamentos y tecnologías sanitarias:. Evaluación económica de medicamentos y tecnologías sanitarias:
63
74
.